News
10h
Zacks Investment Research on MSNSolventum (SOLV) Just Overtook the 200-Day Moving AverageSolventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 200-day moving average, which suggests a ...
Q3 2025 Earnings Conference Call May 8, 2025 10:30 AM ETCompany ParticipantsKellie Smythe - Senior Director of ...
3d
Zacks Investment Research on MSNPfizer (PFE) Just Overtook the 20-Day Moving AverageFrom a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a key level of support. PFE recently overtook the 20-day moving average, and this suggests a ...
While the new range would top fiscal 2024's $728 million, it's below the average analyst estimate of $854 million. The company did not provide any forecasts for profitability. The disparity between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results